• Home
  • A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.

Author List
Piawah S, Hyland C, Umetsu SE, Esserman LJ, Rugo HS, Chien AJ
Publication
NPJ breast cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/57845717
Publication Year
2019
PubMed ID
31240240
Publication Title
Piawah S, Hyland C, Umetsu SE, Esserman LJ, Rugo HS, Chien AJ. A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel. NPJ Breast Cancer. 2019; 5:17.